network member

John Theurer Cancer Center at Hackensack Meridian Health

John Theurer Cancer Center, Hackensack, NJ 07601
John Theurer Cancer Center at Hackensack Meridian Health

About Network Member

In October 2010, the John Theurer Cancer Center unveiled a 155,000-square foot comprehensive cancer facility. The building brings the cancer center’s 14 specialized divisions with research and auxiliary oncology services, including nutrition counseling and psychosocial support, together under one roof. This encourages collaboration and a multidisciplinary approach among practicing physicians and staff. The John Theurer Cancer Center keeps at the forefront of delivering innovative care and providing tomorrow’s treatment today by: Taking multidisciplinary care to a new level with teams of disease-specific experts under one roof Delivering personalized medicine focused on novel therapies, participatory treatment, predictive measures, and preventive care Advancing research through biomarker-driven clinical trials and translational research Providing holistic care that includes a wide range of complementary services important to the well-being of patients that can be easily integrated into their care Creating a comforting environment in a new high-tech, high-touch building. Website: John Theurer Cancer Center
Currently Enrolling

HCRN-BSK22-562

Observational basket trial to predict response to immune checkpoint inhibitors across solid tumors using a live tumor diagnostic platform (CYBRID-02)
Cancer areas:Basket
AdventHealth Orlando
CARTI
John Theurer Cancer Center at Hackensack Meridian Health
Meritus Center for Clinical Research / John R. Marsh Cancer Center
Salinas Valley Health
University of Louisville / James Graham Brown Cancer Center
University of North Carolina Lineberger Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
Enrollment Closed

HCRN-GU18-343

A Phase 2 Study of CAbozantinib in Combination With AtezolizumaB as NeoAdjuvant Treatment for Muscle-Invasive BladdEr Cancer (ABATE)
Cancer areas:Bladder
Froedtert & the Medical College of Wisconsin
John Theurer Cancer Center at Hackensack Meridian Health
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
University of Rochester Medical Center - Wilmot Cancer Institute
Vanderbilt-Ingram Cancer Center
Virginia Commonwealth University
Currently Enrolling

HCRN-GU22-587

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Cancer areas:Kidney
Beth Israel Deaconess Medical Center
Columbia University Irving Medical Center
Dana-Farber Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
John Theurer Cancer Center at Hackensack Meridian Health
Moores Cancer Center at UC San Diego Health
Penn Medicine Abramson Cancer Center
The Ohio State University
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Weill Cornell Medicine
Winship Cancer Institute of Emory University
Yale Cancer Center